Read More 2 minute read Health and Medicine Vosoritide’s first phase 2 study shows increased growth in children with hypochondroplasia Vosoritide’s first global phase 2 study showed an average increased growth rate of 1.8 cm per year in… bychemistadminApril 13, 2024